Last Updated: November 9, 2026

Litigation Details for BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. v. ANOBRI PHARMACEUTICALS US, LLC (D.N.J. 2023)

« Back to Dashboard


BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. v. ANOBRI PHARMACEUTICALS US, LLC (D.N.J. 2023)

Docket ⤷  Start Trial Date Filed 2023-06-29
Court District Court, D. New Jersey Date Terminated 2023-12-18
Cause 35:271 Patent Infringement Assigned To Claire Claudia Cecchi
Jury Demand None Referred To Leda Dunn Wettre
Parties ANOBRI PHARMACEUTICALS US, LLC
Patents 7,284,474; 7,396,341; 7,837,235; 7,896,264; 8,733,341; 9,027,967
Attorneys CHARLES MICHAEL LIZZA
Firms Saul Ewing LLP
Link to Docket External link to docket
Small Molecule Drugs cited in BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. v. ANOBRI PHARMACEUTICALS US, LLC
The small molecule drugs covered by the patents cited in this case are ⤷  Start Trial , ⤷  Start Trial , ⤷  Start Trial , and ⤷  Start Trial .

Details for BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. v. ANOBRI PHARMACEUTICALS US, LLC (D.N.J. 2023)

Date Filed Document No. Description Snippet Link To Document
2023-06-29 External link to document
2023-06-29 48 1 - Terminate Deadlines AND Order ANDAFFIRMATIVE DEFENSES REGARDING U.S. PATENT NOS. 7,284,474 AND 7,896,264 without prejudice. Signed … 18 December 2023 2:23-cv-03531 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.